REQUEST A DEMO
Total
USD $0.00
Search more companies

Jiangsu Hengrui Pharmaceuticals Co.,Ltd (江苏恒瑞医药股份有限公司) (China)

Main Activities: Pharmaceutical and Medicine Manufacturing | Research and Development in the Physical, Engineering, and Life Sciences
Full name: Jiangsu Hengrui Pharmaceuticals Co.,Ltd Profile Updated: March 29, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Chinese Download a sample report

Jiangsu Hengrui Pharmaceuticals Co.,Ltd (江苏恒瑞医药股份有限公司) is based in China, with the head office in Lianyungang. The enterprise operates in the Pharmaceutical and Medicine Manufacturing industry. The company was established on April 28, 1997. It currently has a total number of Above 10,001 (2025) employees. The latest financial highlights indicate a net sales revenue increase of 13.02% in 2025. There was a total growth of 39.36% in Jiangsu Hengrui Pharmaceuticals Co.,Ltd (江苏恒瑞医药股份有限公司)’s total assets over the same period. The net profit margin of Jiangsu Hengrui Pharmaceuticals Co.,Ltd (江苏恒瑞医药股份有限公司) increased by 1.76% in 2025.

Headquarters
No. 7, Kunlun Mountain Road, Economic and Technological Development Zone, Lianyungang City, Jiangsu Province
Lianyungang; Jiangsu; Postal Code: 222000

Contact Details: Purchase the Jiangsu Hengrui Pharmaceuticals Co.,Ltd (江苏恒瑞医药股份有限公司) report to view the information.

Website: http://www.hengrui.com

Basic Information
Total Employees:
Purchase the Jiangsu Hengrui Pharmaceuticals Co.,Ltd (江苏恒瑞医药股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Jiangsu Hengrui Pharmaceuticals Co.,Ltd (江苏恒瑞医药股份有限公司) report to view the information.
Registered Capital:
Purchase the Jiangsu Hengrui Pharmaceuticals Co.,Ltd (江苏恒瑞医药股份有限公司) report to view the information.
Financial Auditors:
Purchase the Jiangsu Hengrui Pharmaceuticals Co.,Ltd (江苏恒瑞医药股份有限公司) report to view the information.
Incorporation Date:
April 28, 1997
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Independent Director
Ownership Details
Purchase this report to view the information.
23.18%
Purchase this report to view the information.
14.35%
Purchase this report to view the information.
7.34%
Purchase this report to view the information.
3.89%
Purchase this report to view the information.
2.77%
Subsidiaries
Beijing Hengsen Innovation Pharmaceutical Technology Co., Ltd.
100%
Beijing Shengdi Pharmaceutical Co., Ltd.
100%
Cadiasun Pharma GmbH
100%
Company Performance
Financial values in the chart are available after Jiangsu Hengrui Pharmaceuticals Co.,Ltd (江苏恒瑞医药股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
13.02%
Total Operating Revenue
12.9%
Operating Profit
20.02%
Net Profit/Loss for the Period
21.78%
Total Assets
39.36%
Total Equity
34.08%
Operating Profit Margin
1.65%
Net Profit Margin
1.76%
Return on Equity (ROE)
-1.26%
Quick Ratio
-1421.49%
Cash Ratio
-0.4%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?